Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

614
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
614
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.9K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.9K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

726
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective evaluation of the effect of stopping estrogen-containing contraceptives on serum CBG and cortisol levels.

The Journal of clinical endocrinology and metabolism·2026
Same author

National comparability and inter-laboratory performance of cortisol immunoassays and LC-MS/MS methods.

Clinical chemistry and laboratory medicine·2026
Same author

Correct neonatal free thyroxine reference intervals are crucial to detect central congenital hypothyroidism.

European journal of endocrinology·2026
Same author

Cut-off values of urinary free cortisol and cortisone for diagnosing neoplastic hypercortisolism.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Subclinical Hyperthyroidism, Cardiovascular Disease and All-Cause Mortality: Insights from a Large Dutch Primary Care Cohort Study.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Salivary testosterone reference intervals for adult women and men.

Clinical chemistry and laboratory medicine·2026

Related Experiment Video

Updated: Mar 24, 2026

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
14:40

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings

Published on: October 25, 2015

9.9K

Glucocorticoid Programming in Very Preterm Birth.

Martijn J J Finken1, Bibian van der Voorn, Annemieke C Heijboer

  • 1Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands.

Hormone Research in Paediatrics
|March 5, 2016
PubMed
Summary
This summary is machine-generated.

Very preterm infants often have impaired adrenocortical function, leading to long-term health issues. This review explores how their hypothalamus-pituitary-adrenal axis activity changes with age, impacting future health outcomes.

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

6.2K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
14:40

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings

Published on: October 25, 2015

9.9K
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

6.2K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Developmental Biology

Background:

  • Very preterm infants (<32 weeks gestation) exhibit compromised responses to physiological stress due to adrenocortical insufficiency.
  • Postnatally, these infants may develop features of increased glucocorticoid bioactivity later in life.
  • Sustained elevation in hypothalamus-pituitary-adrenal axis activity post-birth is hypothesized to link prematurity with long-term health risks.

Purpose of the Study:

  • To review studies on adrenocortical function in very preterm newborns.
  • To examine the age-related changes in the hypothalamus-pituitary-adrenal axis in this population.
  • To explore the potential mechanisms linking early adrenocortical function to long-term outcomes.

Main Methods:

  • Literature review of studies investigating adrenocortical function in very preterm infants.
  • Analysis of studies examining the developmental trajectory of the hypothalamus-pituitary-adrenal axis.
  • Synthesis of evidence on the association between prematurity, adrenocortical activity, and later-life health.

Main Results:

  • Very preterm infants show initial adrenocortical insufficiency.
  • Evidence suggests a persistent elevation in hypothalamus-pituitary-adrenal axis activity beyond infancy.
  • These alterations are associated with adverse effects on growth, body composition, metabolism, and neurodevelopment.

Conclusions:

  • Adrenocortical function and hypothalamus-pituitary-adrenal axis regulation in very preterm infants are critical factors influencing long-term health.
  • Understanding these changes may elucidate the mechanisms behind increased chronic disease risk in this population.
  • Further research is needed to fully elucidate the mechanisms and inform interventions.